Literature DB >> 15792754

Lysyl oxidase expression in bronchogenic carcinoma.

Amy R Woznick1, Amy L Braddock, Mohanpal Dulai, Marilyn L Seymour, Rose E Callahan, Robert J Welsh, Gary W Chmielewski, Gerald B Zelenock, Charles J Shanley.   

Abstract

BACKGROUND: Lysyl oxidase catalyzes a key step in the cross-linking of collagen and elastin in the extracellular matrix. Recent studies have documented differential lysyl oxidase expression in the stromal reaction to colon, breast, prostate, and lung cancer. The present study was undertaken to test the hypothesis that lysyl oxidase mRNA and protein expression decrease with advancing tumor stage in patients with bronchogenic carcinoma.
METHODS: Tumor specimens were obtained from 17 patients undergoing resection for bronchogenic carcinoma. Real-time polymerase chain reaction was used to determine steady-state lysyl oxidase mRNA expression, and protein expression was qualitatively assessed by immunohistochemistry.
RESULTS: Real-time polymerase chain reaction studies documented a 3.4-fold graded decrease in lysyl oxidase mRNA levels as tumors progressed from stage I to IV. Similar qualitative changes in lysyl oxidase protein expression were demonstrated by immunohistochemistry.
CONCLUSIONS: These results support the hypothesis that variations in lysyl oxidase expression may correlate with the invasive and metastatic potential of bronchogenic carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15792754     DOI: 10.1016/j.amjsurg.2004.11.031

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  20 in total

1.  Lysyl oxidase is associated with the epithelial-mesenchymal transition of gastric cancer cells in hypoxia.

Authors:  Hiroaki Kasashima; Masakazu Yashiro; Haruhito Kinoshita; Tatsunari Fukuoka; Tamami Morisaki; Go Masuda; Katsunobu Sakurai; Naoshi Kubo; Masaichi Ohira; Kosei Hirakawa
Journal:  Gastric Cancer       Date:  2015-06-23       Impact factor: 7.370

2.  Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration.

Authors:  Ling Wei; Xian-Rang Song; Ju-Jie Sun; Xing-Wu Wang; Li Xie; Li-Yan Lv
Journal:  Cancer Biother Radiopharm       Date:  2012-11-09       Impact factor: 3.099

3.  Silencing of hypoxia-inducible tumor suppressor lysyl oxidase gene by promoter methylation activates carbonic anhydrase IX in nasopharyngeal carcinoma.

Authors:  Fion L Sung; Yan Cui; Edwin P Hui; Lili Li; Thomas Ks Loh; Qian Tao; Anthony Tc Chan
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

Review 4.  The role of copper in tumour angiogenesis.

Authors:  Sarah A Lowndes; Adrian L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

5.  Activation of cellular chemotactic responses to chemokines coupled with oxidation of plasma membrane proteins by lysyl oxidase.

Authors:  Héctor A Lucero; Joni M Mäki; Herbert M Kagan
Journal:  J Neural Transm (Vienna)       Date:  2011-04-21       Impact factor: 3.575

6.  Lysyl oxidase, extracellular matrix remodeling and cancer metastasis.

Authors:  Qian Xiao; Gaoxiang Ge
Journal:  Cancer Microenviron       Date:  2012-04-13

Review 7.  Lysyl oxidase, a critical intra- and extra-cellular target in the lung for cigarette smoke pathogenesis.

Authors:  Wande Li; Jing Zhou; Lijun Chen; Zhijun Luo; Yinzhi Zhao
Journal:  Int J Environ Res Public Health       Date:  2011-01-19       Impact factor: 3.390

8.  Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer.

Authors:  Neill Patani; Wen Jiang; Robert Newbold; Kefah Mokbel
Journal:  J Carcinog       Date:  2010-11-12

9.  Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide.

Authors:  Ziyang Yu; Seiichi Sato; Philip C Trackman; Kathrin H Kirsch; Gail E Sonenshein
Journal:  PLoS One       Date:  2012-03-15       Impact factor: 3.240

10.  Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathway.

Authors:  Yu Wang; Jun Ma; Haoran Shen; Chengjie Wang; Yueping Sun; Stephen B Howell; Xinjian Lin
Journal:  Oncol Rep       Date:  2014-08-28       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.